Clinical trials recruiting for NSCLC, Stage III
8
Recruiting trials
5
US states with sites
5
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 2Phase 3 1Not applicable 5
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Carboplatin | 1 |
| Cisplatin | 1 |
| Durvalumab | 1 |
| Leuprorelin acetate + Sintilimab | 1 |
| Paclitaxel | 1 |
| Pemetrexed | 1 |
| Repotrectinib | 1 |
| Sintilimab | 1 |
| Tremelimumab | 1 |
| sintilimab+IBI310+chemotherapy | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Kansas | 1 |
| Rhode Island | 1 |
| Texas | 1 |
| Utah | 1 |
Top cities
Galveston, Texas 1Kansas City, Kansas 1Providence, Rhode Island 1Salt Lake City, Utah 1Stanford, California 1
Self-screener
Recruiting trials
- A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung Cancer
- A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
- Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung Cancer
- Lung Cancer Registry
- PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study
- Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC
- Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC
- Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients
Related conditions
Trials recruiting for NSCLC, Stage III often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180NSCLC Stage IV 20NSCLC Stage II 4Non-small cell lung cancer 507SCLC, Limited Stage 7SCLC, Extensive Stage 12NSCLC, Stage I 5Locally Advanced Lung Carcinoma 3
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for NSCLC, Stage III trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.